Context Therapeutics Inc. — Director's Dealing 2022

Dec 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2022-12-16

Reporting Person: Lehr Martin A. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-16	Common Stock	P	20000	$0.7398	Acquired	122583	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	820190	Indirect